APACHE Medical Systems Announces Multiple New Contracts for APACHE III Critical Care Series TM Products and Services
McLean, VA -- February 10, 1998 -- APACHE Medical Systems, Inc. (NASDAQ:AMSI), today announced the signing of four new clients for systems and services from the Company1s APACHE III Critical Care Series product line. These new clients include: Moses H. Cone Health System, Greensboro, North Carolina; St. Mary1s Hospital, Huntington, West Virginia; New Hanover Regional Medical Center, Wilmington, North Carolina; and Palmetto Richland Memorial Hospital in Columbia, South Carolina.
The APACHE III Critical Care Series products provide risk-adjusted hospital and health system performance data and comparison to Best Demonstrated Practices and norms. This information is essential for hospitals to identify priorities for quality improvement, measure the results of these efforts, and assist in daily patient care management. The system includes two main modules. Voyager+ provides retrospective analysis, while the Discover+ module offers concurrent and predictive information in support of day-to-day patient care decisions, including at the bedside. All Critical Care Series products are PC-based within a client-server architecture, and are Year 2000 ready.
3These hospitals1 commitment to APACHE demonstrates the growing appeal to both the medical community and hospital administration of our evidence-based solutions for the effective management of high-cost, high-risk patients,ý said James L. Elder, the Company1s Vice President of Sales. 3By using the APACHE Critical Care Series and related APACHE Best Care TM Clinical Performance Improvement Programs, our clients are able to realize - and document - substantial and sustainable cost savings while improving care quality, utilization and patient satisfaction.ý
APACHE Medical Systems, Inc. is the recognized leader in the development of risk-adjustment models, clinical decision support tools and quality improvement programs for the care of high-risk, high-cost patients. The Company1s products and services enable health systems, hospitals and providers to apply an evidence-based approach to achieve clinical performance excellence, reduce cost and compete effectively under managed care.
Well-known internationally for the APACHE III methodology for critical care, the Company1s programs are today helping providers to better manage the clinical, financial and patient satisfaction outcomes of high-risk, high-cost patients in critical, acute, cardiovascular, HIV/AIDS and sub-acute care.
Both APACHE1s Critical Care Series and Acute Care Voyager+ products are accepted by the Joint Commission on Accreditation of Healthcare Organizations for reporting under the 3ORYXý performance measurement initiative. |
